Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
4.02%
↑ 107% above average
Average (9y)
-59.78%
Historical baseline
Range
High:78.03%
Low:-528.43%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 4.02% |
| 2023 | -4.89% |
| 2022 | 8.91% |
| 2021 | -19.61% |
| 2020 | 58.53% |
| 2019 | -169.22% |
| 2018 | 32.35% |
| 2017 | 78.03% |
| 2016 | -528.43% |
| 2015 | -57.53% |